Skip to main content
. 2021 Feb 25;12:607044. doi: 10.3389/fimmu.2021.607044

Figure 5.

Figure 5

Time kinetics shows the increase of miR-155 and the decrease of its targets suppressor of cytokine signaling 1 (SOCS1) and SH-2 containing inositol 5’-polyphosphatase 1 (SHIP1) in T1 cells following bortezomib treatment. Human lymphoblast T1 cells were treated in vitro with 10 nM bortezomib for 2, 4, 6, 9, 12, 18, and 24 h. The cells were collected at each time point and analyzed for miR-155 expression by RT-PCR and for SOCS1 and SHIP1 protein levels by Western blotting. The expression of miR-155 (A) and SOCS1 and SHIP1 protein levels (B) are shown by function of time in T1 cells upon 10 nM bortezomib treatment. Numbers above the bands are the indicated ratios of the densitometry values. (C) Bar graphs depict SHIP1:β-actin ratios for fold changes in SHIP1 protein as calculated from the densitometry values. Data are presented as mean values ± SD from four independent experiments with triplicates; * p < 0.0072, ** p < 0.0001, *** p < 0.00001 (ANOVA, one-way), compared to 0 h (A, C).